Population Statistic: Read. React. Repeat.
Tuesday, December 28, 2020

Ecstacy moves from the clubs to the deathbeds as the Multidisciplinary Association for Psychedelic Studies (MAPS) is embarking upon a pilot program, under FDA approval, for giving the drug to terminal cancer patients to help them pass more gently into that good night.

MAPS, of course, has long advocated using mind/mood-altering substances for these purposes.

Categorically, of all drug-induced effects I’ve experienced (first- or secondhand), X is by far the most unsettling to me. The swings from mellowness to euphoria and back again can be downright eerie, and generally unsettling.

- Costa Tsiokos, Tue 12/28/2004 11:29:13 PM
Category: Science | Permalink |

Trackback this entry: Right-click and copy link
1 Feedback
  1. ‘First or second-hand’ . . . smooth circumvention there.

    And let me say I think this is a great idea.

    Comment by r* — 12/30/2004 @ 11:32:31 AM

RSS feed for feedback on this post.

Leave a comment

Comment form closed to reduce comment-spam opportunities. Sorry about the inconvenience. Please feel free to respond to this post via Trackback and/or Pingback!